Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
152.7 USD | +0.37% |
|
+0.79% | +58.32% |
06-26 | Monetary policy is getting even more confusing | ![]() |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.32% | 14.43B | |
+20.63% | 127B | |
+25.07% | 27.67B | |
-20.17% | 20.33B | |
-17.15% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+149.98% | 12.49B | |
-10.27% | 9.84B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-07-2019 through Jan-10-2019